Skip to main content
. 2015 Mar 16;61(1):120–128. doi: 10.1093/cid/civ219

Table 1.

Changes in Lymphocyte Populations From Autologous Stem Cell Transplant to Resolution of Viremia

Days Post-Transplant
−41 21 42 472
Viral load <50 940 <50 <50
Percentage of live lymphocytes
NK cells (CD56+)a 0.18 1.51 1.58 2.29
 Of which CD16+CD56bright ND 0.68 2.69 2.20
 Of which CD16+CD56dim ND 77.7 84.8 81.4
 Of which CD16−CD56bright ND 1.02 2.28 4.00
 Of which CD16−CD56dim ND 22.6 11.2 0.00
NKT-like cells (CD3+CD56+) 2.30 3.27 2.01 1.59
CD3 T cells (CD3+CD56−) 92.8 86.4 96.0 88.6
CD8 T cells (CD3+CD8+) 23.4 69.1 74.1 46.5
B cells (CD3−CD19+) 0.00 0.06 0.12 2.25
Proliferation: % Ki67+
 NK cells 92.5 92.1 81.5 10.5
 NKT cells 58.3 63.0 75.3 3.20
 CD8+ T cells 100 99.7 99.8 1.62
 CD4+ T cells (CD3+CD8−CD56−) 90.9 90.5 99.0 1.77
 B cells ND 50.0 39.5 4.24

Lymphocyte populations were assessed by flow cytometry and are shown as a percentage of the total live cells (as determined by an amine-reactive viability dye) present in each sample. Autologous stem cells for day −41 or peripheral blood mononuclear cell for days 21,42, and 472.

Abbreviations: ND, not determined due to too few cells in the parent gate for analysis; NK, natural killer.

a Defining markers for each population are shown in parentheses.